CRL

Charles River Laboratories International
D

CRL

300.02
USD
-0.25
(-0.08%)
Market Closed
Last updated: · Delayed 15 min
Volume
17,814
EPS
11
Div Yield
-
P/E
-62
Market Cap
14,322,616,377
Overview
Related Instruments
A
A
D
Agilent Technologies
169.900
-3.070(-1.77%)
ABT
ABT
D
Abbott Laboratories
104.070
-0.810(-0.77%)
BDX
BDX
D
Becton Dickinson and Co
190.720
-0.830(-0.43%)
DGX
DGX
D
Quest Diagnostics
234.900
-0.080(-0.03%)
IDXX
IDXX
D
IDEXX Laboratories
555.81
-4.61(-0.82%)
LH
LH
D
Laboratory Corp
318.99
1.11(0.35%)
T
TFX
D
Teleflex
129.460
-1.000(-0.77%)
TMO
TMO
D
Thermo Fisher Scientific
679.35
-10.85(-1.57%)
WAT
WAT
D
Waters Corp
434.31
-2.68(-0.61%)
More

Title: Charles River Laboratories International

Sector: Healthcare
Industry: Diagnostics & Research
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.